This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of West Pharmaceutical Services Inc. plummeted 38.2% to $199.11 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.0% to 6,115.07 and the Dow Jones Industrial Average rising 0.8% to 44,711.43.
This was the stock's third consecutive day of losses.
West Pharmaceutical Services Inc. closed 50.3% short of its 52-week high of $400.88, which the company achieved on March 21st.
The stock underperformed when compared to some of its competitors, as Abbott Laboratories rose 1.0% to $131.79, Becton Dickinson & Co. fell 0.4% to $225.01, and Baxter International Inc. rose 1.09% to $30.62.
Trading volume totaled 5.1 million, compared to the 50-day average of 467,948.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 13, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。